Showing results (241-250 of 339) with videos related to

Sort By:
Pageof 34
The Journal of Infectious Diseases|September 11, 2019
Immunogenicity, Lot Consistency, and Extended Safety of rVSVΔG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy AdultsScott A Halperin, Rituparna Das, Matthew T Onorato, et al.
Lancet Regional Health. Americas|June 15, 2026
Epidemiology and severity of pediatric influenza hospitalizations before and during the COVID-19 pandemic: a surveillance study of the Canadian immunization monitoring program (IMPACT), 2012-2023Costanza Di Chiara, Jesse Papenburg, Julie A Bettinger, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 13, 2023
Outcomes of immunocompromised children hospitalized for Influenza, 2010-2021, the Canadian Immunization Monitoring Program Active (IMPACT)Tilmann Schober, Shaun K Morris, Julie A Bettinger, et al.
Vaccine|March 31, 2025
Characterization of Canadian Neisseria meningitidis serogroup B isolates and factor-H binding protein expression, data from the Canadian Immunization Monitoring Program Active (IMPACT), 2013-2020Kevin Meesters, Manish Sadarangani, Stephen A Clark, et al.
Vaccine|July 21, 2011
Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussisSrinivas Garlapati, Nelson F Eng, Tadele G Kiros, et al.
The Pediatric Infectious Disease Journal|June 4, 2005
Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccinePenelope H Dennehy, Rebecca C Brady, Scott A Halperin, et al.
The Journal of Infectious Diseases|May 27, 2017
Six-Month Safety Data of Recombinant Vesicular Stomatitis Virus-Zaire Ebola Virus Envelope Glycoprotein Vaccine in a Phase 3 Double-Blind, Placebo-Controlled Randomized Study in Healthy AdultsScott A Halperin, Jose R Arribas, Richard Rupp, et al.
BMC Public Health|June 3, 2014
Knowledge, attitudes, beliefs and behaviours of older adults about pneumococcal immunization, a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) investigationAmy Schneeberg, Julie A Bettinger, Shelly McNeil, et al.
BMC Public Health|October 13, 2024
Exploring the effects of COVID-19 outbreak control policies on services offered to people experiencing homelessnessAlexa J Davis, Donna M Halperin, Brian R Condran, et al.
Vaccine|August 2, 2011
Tolerability and antibody response in adolescents and adults revaccinated with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed (Tdap) 4-5 years after a previous doseScott A Halperin, Shelly McNeil, Joanne Langley, et al.
Pageof 34